Veterinary Medicines

Rivalgin, 500mg/ml, Solution for injection

Authorised
  • Metamizole sodium monohydrate
Download as PDF

Product identification

Medicine name:
Rivalgin, 500mg/ml, Solution for injection
Rivalgin Vet. 500 mg/ml injektionsvæske, opløsning
Active substance:
  • Metamizole sodium monohydrate
Target species:
  • Cattle
  • Pig
  • Dog
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Metamizole sodium monohydrate
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        48
        hour
      • Meat and offal
        12
        day
    • Pig
      • Meat and offal
        12
        day
    • Dog
  • Intravenous use
    • Horse
      • Milk
        no withdrawal period
      • Meat and offal
        5
        day
    • Cattle
      • Milk
        48
        hour
      • Meat and offal
        12
        day
    • Pig
      • Meat and offal
        12
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Glass Vial 5 x 100.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 61671
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0152/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Hungary
  • Iceland
  • Italy
  • Lithuania
  • Norway
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, OPLØSNING 500 MG-ML)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."